Search

Search Constraints

You searched for: Author/Creator Solomon, Ajantha

Search Results

1. Human Immunodeficiency Virus (HIV)–Infected CCR6+ Rectal CD4+ T Cells and HIV Persistence On Antiretroviral Therapy. (4th December 2019)

2. The impact of immune checkpoint therapy on the latent reservoir in HIV-infected individuals with cancer on antiretroviral therapy. (1st August 2021)

3. Neurotoxicity with high-dose disulfiram and vorinostat used for HIV latency reversal. (1st January 2022)

4. Cell-Associated Human Immunodeficiency Virus (HIV) Ribonucleic Acid Has a Circadian Cycle in Males With HIV on Antiretroviral Therapy. (16th October 2021)

5. Sex-Based Differences in Human Immunodeficiency Virus Type 1 Reservoir Activity and Residual Immune Activation. (29th October 2018)

6. Human Immunodeficiency Virus Persistence and T-Cell Activation in Blood, Rectal, and Lymph Node Tissue in Human Immunodeficiency Virus–Infected Individuals Receiving Suppressive Antiretroviral Therapy. (7th February 2017)

7. Polymorphisms in the CD14 and TLR4 genes independently predict CD4+ T-cell recovery in HIV-infected individuals on antiretroviral therapy. (10th September 2016)

8. Programmed cell death-1 contributes to the establishment and maintenance of HIV-1 latency. (17th July 2018)

10. Variation in cell-associated unspliced HIV RNA on antiretroviral therapy is associated with the circadian regulator brain-and-muscle-ARNT-like-1. (24th September 2018)